Hilde Windels

TLDR

Hilde Windels is a Ghent-based biotech finance executive with over 20 years of experience in corporate finance and capital markets, best known as CFO and later Deputy CEO of Biocartis.

Overview

Hilde Windels is listed by Omar Mohout among the most connected women in the Ghent tech ecosystem, alongside Annie Vereecken, Danae Delbeke, Greet Vandewalle, Sophie Manigart, and Isabelle Tennstedt.

She began her career at BBL (later ING) in 1988 before moving into biotech. She joined Ghent-based Devgen as VP Finance in 1998 and became CFO in 1999, overseeing the company's EUR 30 million Venture Capital raise and its Euronext IPO in 2005. She joined Biocartis as CFO in July 2011, helped take the company public, and rose to Deputy CEO. She has also served as interim CFO at TiGenix and as a board member at Ablynx and ERYTECH.

Career History

• Credit Analyst and Commercial Banker, BBL/ING (1988-1998)
• VP Finance, then CFO, Devgen NV (1998-2008, led EUR 30M raise and Euronext IPO)
• Interim CFO, TiGenix
• CFO, Biocartis NV (2011-2015)
• Deputy CEO, Biocartis NV (2015-2017)
• Board Member, Ablynx; ERYTECH

Sources

• https://www.crunchbase.com/person/hilde-windels
• https://trends.knack.be/economie/mensen/hilde-windels-de-pitbull-van-biocartis/article-normal-566009.html
• https://www.gimv.com/en/team/hilde-windels